Lumbar Puncture — Collecting Cerebrospinal Fluid
Placeholder: sterile lumbar puncture obtains CSF for biomarker testing.
- ~12 mL: Sample volume (Placeholder detail)
- L3–L4: Needle level (Placeholder detail)
- ~20 min: Procedure time (Placeholder detail)
- Headache: Common side effect (Placeholder detail)
Collection procedure placeholder heading
Placeholder: needle insertion, fluid draw, and tube handling steps summarized briefly.
Measuring Total Tau and Phospho-Tau Levels
Placeholder: immunoassays measure total tau and phosphorylated tau concentrations.
- ELISA/Simoa: Assay type (Placeholder detail)
- 100–900 pg/mL: Total tau range (Placeholder detail)
- 15–120 pg/mL: P-tau range (Placeholder detail)
- ~1–2 days: Turnaround (Placeholder detail)
Biomarker quantification placeholder heading
Placeholder: antibody-based detection quantifies tau isoforms in CSF sample.
CSF Tau/Amyloid Ratio Interpretation
Placeholder: tau-to-amyloid-beta ratio helps characterize pathology pattern.
- t-tau/Aβ42: Ratio metric (Placeholder detail)
- >0.8: High-risk ratio (Placeholder detail)
- ADNI-derived: Reference cohort (Placeholder detail)
- AD signature: Use case (Placeholder detail)
Ratio computation placeholder heading
Placeholder: combining tau and amyloid values into a single interpretive ratio.
Diagnostic Threshold Classification
Placeholder: measured biomarker levels compared against clinical cutoffs.
- ~450 pg/mL: Total tau cutoff (Placeholder detail)
- ~80 pg/mL: P-tau cutoff (Placeholder detail)
- 3 tiers: Classification bands (Placeholder detail)
- Support dx: Clinical use (Placeholder detail)
Threshold logic placeholder heading
Placeholder: cutoff bands classify results as normal, borderline, or elevated.
CSF vs Blood Biomarker Comparison
Placeholder: comparing invasive CSF testing with emerging blood-based assays.
- p-tau217: Blood assay (Placeholder detail)
- CSF > blood: Invasiveness (Placeholder detail)
- ~85–90%: Concordance (Placeholder detail)
- Blood rising: Trend (Placeholder detail)
Modality comparison placeholder heading
Placeholder: relative merits of CSF and blood-based tau biomarker testing.
Placeholder: blood-based p-tau assays may reduce reliance on lumbar puncture.